---
keywords:
  - Bayesian Optimization
  - Multimodal Gene Embeddings
  - Enrichment Analysis
  - Pathway-Level Explanations
category: cs.LG
publish_date: 2025-09-25
arxiv_id: 2509.19988
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-25T16:59:23.655595",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Bayesian Optimization",
    "Multimodal Gene Embeddings",
    "Enrichment Analysis",
    "Pathway-Level Explanations"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Bayesian Optimization": 0.78,
    "Multimodal Gene Embeddings": 0.74,
    "Enrichment Analysis": 0.75,
    "Pathway-Level Explanations": 0.73
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Bayesian Optimization",
        "canonical": "Bayesian Optimization",
        "aliases": [
          "BO"
        ],
        "category": "broad_technical",
        "rationale": "Bayesian Optimization is a fundamental technique in machine learning and optimization, facilitating connections across various domains.",
        "novelty_score": 0.45,
        "connectivity_score": 0.85,
        "specificity_score": 0.65,
        "link_intent_score": 0.78
      },
      {
        "surface": "Multimodal Gene Embeddings",
        "canonical": "Multimodal Gene Embeddings",
        "aliases": [],
        "category": "unique_technical",
        "rationale": "This concept represents a novel approach in integrating multiple data types for gene analysis, enhancing biological data interpretation.",
        "novelty_score": 0.72,
        "connectivity_score": 0.68,
        "specificity_score": 0.82,
        "link_intent_score": 0.74
      },
      {
        "surface": "Enrichment Analysis",
        "canonical": "Enrichment Analysis",
        "aliases": [],
        "category": "specific_connectable",
        "rationale": "Enrichment Analysis is crucial for gene prioritization, linking experimental designs to biological pathways.",
        "novelty_score": 0.55,
        "connectivity_score": 0.79,
        "specificity_score": 0.77,
        "link_intent_score": 0.75
      },
      {
        "surface": "Pathway-Level Explanations",
        "canonical": "Pathway-Level Explanations",
        "aliases": [],
        "category": "unique_technical",
        "rationale": "Provides mechanistic insights into gene perturbations, facilitating deeper biological understanding.",
        "novelty_score": 0.68,
        "connectivity_score": 0.72,
        "specificity_score": 0.81,
        "link_intent_score": 0.73
      }
    ],
    "ban_list_suggestions": [
      "genomic perturbation",
      "drug discovery",
      "therapeutic target"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Bayesian Optimization",
      "resolved_canonical": "Bayesian Optimization",
      "decision": "linked",
      "scores": {
        "novelty": 0.45,
        "connectivity": 0.85,
        "specificity": 0.65,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "Multimodal Gene Embeddings",
      "resolved_canonical": "Multimodal Gene Embeddings",
      "decision": "linked",
      "scores": {
        "novelty": 0.72,
        "connectivity": 0.68,
        "specificity": 0.82,
        "link_intent": 0.74
      }
    },
    {
      "candidate_surface": "Enrichment Analysis",
      "resolved_canonical": "Enrichment Analysis",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.79,
        "specificity": 0.77,
        "link_intent": 0.75
      }
    },
    {
      "candidate_surface": "Pathway-Level Explanations",
      "resolved_canonical": "Pathway-Level Explanations",
      "decision": "linked",
      "scores": {
        "novelty": 0.68,
        "connectivity": 0.72,
        "specificity": 0.81,
        "link_intent": 0.73
      }
    }
  ]
}
-->

# BioBO: Biology-informed Bayesian Optimization for Perturbation Design

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250925|20250925]] [[categories/cs.LG|cs.LG]]
**PDF**: [Download](https://arxiv.org/pdf/2509.19988.pdf)
**Category**: cs.LG
**Published**: 2025-09-25
**ArXiv ID**: [2509.19988](https://arxiv.org/abs/2509.19988)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-23/Adaptive Kernel Design for Bayesian Optimization Is a Piece of CAKE with LLMs_20250923|Adaptive Kernel Design for Bayesian Optimization Is a Piece of CAKE with LLMs]] (84.9% similar)
- [[2025-09-22/Gradient-Free Sequential Bayesian Experimental Design via Interacting Particle Systems_20250922|Gradient-Free Sequential Bayesian Experimental Design via Interacting Particle Systems]] (84.7% similar)
- [[2025-09-23/An AI-powered Bayesian generative modeling approach for causal inference in observational studies_20250923|An AI-powered Bayesian generative modeling approach for causal inference in observational studies]] (82.1% similar)
- [[2025-09-24/Bayesian Calibration and Model Assessment of Cell Migration Dynamics with Surrogate Model Integration_20250924|Bayesian Calibration and Model Assessment of Cell Migration Dynamics with Surrogate Model Integration]] (81.2% similar)
- [[2025-09-23/Enhancing Performance and Calibration in Quantile Hyperparameter Optimization_20250923|Enhancing Performance and Calibration in Quantile Hyperparameter Optimization]] (80.8% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Bayesian Optimization|Bayesian Optimization]]
**ğŸ”— Specific Connectable**: [[keywords/Enrichment Analysis|Enrichment Analysis]]
**âš¡ Unique Technical**: [[keywords/Multimodal Gene Embeddings|Multimodal Gene Embeddings]], [[keywords/Pathway-Level Explanations|Pathway-Level Explanations]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.19988v1 Announce Type: cross 
Abstract: Efficient design of genomic perturbation experiments is crucial for accelerating drug discovery and therapeutic target identification, yet exhaustive perturbation of the human genome remains infeasible due to the vast search space of potential genetic interactions and experimental constraints. Bayesian optimization (BO) has emerged as a powerful framework for selecting informative interventions, but existing approaches often fail to exploit domain-specific biological prior knowledge. We propose Biology-Informed Bayesian Optimization (BioBO), a method that integrates Bayesian optimization with multimodal gene embeddings and enrichment analysis, a widely used tool for gene prioritization in biology, to enhance surrogate modeling and acquisition strategies. BioBO combines biologically grounded priors with acquisition functions in a principled framework, which biases the search toward promising genes while maintaining the ability to explore uncertain regions. Through experiments on established public benchmarks and datasets, we demonstrate that BioBO improves labeling efficiency by 25-40%, and consistently outperforms conventional BO by identifying top-performing perturbations more effectively. Moreover, by incorporating enrichment analysis, BioBO yields pathway-level explanations for selected perturbations, offering mechanistic interpretability that links designs to biologically coherent regulatory circuits.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ìœ ì „ì ë³€í˜• ì‹¤í—˜ì˜ íš¨ìœ¨ì  ì„¤ê³„ë¥¼ ìœ„í•´ ì œì•ˆëœ Biology-Informed Bayesian Optimization (BioBO) ë°©ë²•ë¡ ì„ ì†Œê°œí•©ë‹ˆë‹¤. BioBOëŠ” ë² ì´ì§€ì•ˆ ìµœì í™”ì— ìƒë¬¼í•™ì  ì‚¬ì „ ì§€ì‹ê³¼ ë‹¤ì¤‘ ëª¨ë“œ ìœ ì „ì ì„ë² ë”©, ê·¸ë¦¬ê³  ìœ ì „ì ìš°ì„ ìˆœìœ„ ê²°ì •ì„ ìœ„í•œ í’ë¶€í•œ ë¶„ì„ì„ í†µí•©í•˜ì—¬ ëŒ€ë¦¬ ëª¨ë¸ë§ê³¼ íšë“ ì „ëµì„ í–¥ìƒì‹œí‚µë‹ˆë‹¤. ì´ ë°©ë²•ì€ ìœ ë§í•œ ìœ ì „ìë¥¼ íƒìƒ‰í•˜ë©´ì„œë„ ë¶ˆí™•ì‹¤í•œ ì˜ì—­ì„ íƒìƒ‰í•  ìˆ˜ ìˆë„ë¡ ì„¤ê³„ë˜ì—ˆìŠµë‹ˆë‹¤. ì‹¤í—˜ ê²°ê³¼, BioBOëŠ” ë¼ë²¨ë§ íš¨ìœ¨ì„±ì„ 25-40% í–¥ìƒì‹œí‚¤ê³ , ê¸°ì¡´ì˜ ë² ì´ì§€ì•ˆ ìµœì í™”ë³´ë‹¤ ë›°ì–´ë‚œ ì„±ëŠ¥ì„ ë³´ì˜€ìŠµë‹ˆë‹¤. ë˜í•œ, ê²½ë¡œ ìˆ˜ì¤€ì˜ ì„¤ëª…ì„ ì œê³µí•˜ì—¬ ì„¤ê³„ì™€ ìƒë¬¼í•™ì  ê·œì œ íšŒë¡œ ê°„ì˜ ê¸°ê³„ì  í•´ì„ ê°€ëŠ¥ì„±ì„ ë†’ì˜€ìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. BioBOëŠ” ìƒë¬¼í•™ì  ì‚¬ì „ ì§€ì‹ì„ í™œìš©í•˜ì—¬ ìœ ë§í•œ ìœ ì „ì íƒìƒ‰ì„ ê°•í™”í•˜ëŠ” ë°©ë²•ì…ë‹ˆë‹¤.
- 2. BioBOëŠ” ë‹¤ì¤‘ ëª¨ë“œ ìœ ì „ì ì„ë² ë”©ê³¼ í’ë¶€í™” ë¶„ì„ì„ í†µí•©í•˜ì—¬ ëŒ€ë¦¬ ëª¨ë¸ë§ê³¼ íšë“ ì „ëµì„ ê°œì„ í•©ë‹ˆë‹¤.
- 3. BioBOëŠ” ê¸°ì¡´ì˜ ë² ì´ì§€ì•ˆ ìµœì í™”ë³´ë‹¤ 25-40% ë” ë†’ì€ ë¼ë²¨ë§ íš¨ìœ¨ì„±ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.
- 4. BioBOëŠ” ì„ íƒëœ ìœ ì „ì ë³€í˜•ì— ëŒ€í•œ ê²½ë¡œ ìˆ˜ì¤€ì˜ ì„¤ëª…ì„ ì œê³µí•˜ì—¬ ë©”ì»¤ë‹ˆì¦˜ì  í•´ì„ ê°€ëŠ¥ì„±ì„ ë†’ì…ë‹ˆë‹¤.
- 5. BioBOëŠ” ê³µê³µ ë²¤ì¹˜ë§ˆí¬ì™€ ë°ì´í„°ì…‹ ì‹¤í—˜ì—ì„œ ì¼ê´€ë˜ê²Œ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë³´ì…ë‹ˆë‹¤.


---

*Generated on 2025-09-25 16:59:23*